<sup>18</sup>F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital

<sup>18</sup>F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital

Aim: To perform a comprehensive analysis of discordances between contrast-enhanced CT (ceCT) and <sup>18</sup>F-FDG PET/CT in the evaluation of the extra-cerebral treatment monitoring in patients with stage IV melanoma. Materials and methods: We conducted a retrospective monocentric obse...

Full description

Bibliographic Details
Main Authors: Jean-Baptiste Le Goubey, Charline Lasnon, Ines Nakouri, Laure Césaire, Michel de Pontville, Catherine Nganoa, Diane Kottler, Nicolas Aide
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
<sup>18</sup>F-FDG PET/CT
contrast-enhanced CT
melanoma
metastases
tyrosine kinase inhibitors
Immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2075-4418/11/7/1198

Internet

https://www.mdpi.com/2075-4418/11/7/1198

Similar Items